We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$17.2B
AUM Growth
+$2.21B
Cap. Flow
+$1.86B
Cap. Flow %
10.79%
Top 10 Hldgs %
36.31%
Holding
2,528
New
540
Increased
670
Reduced
696
Closed
576

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$144M
2
SPOT icon
Spotify
SPOT
+$84.9M
3
VRT icon
Vertiv
VRT
+$61.6M
4
CHRW icon
C.H. Robinson
CHRW
+$57.4M
5
CNM icon
Core & Main
CNM
+$56.8M

Sector Composition

Rank Sector Weight
1 Technology 12.44%
2 Industrials 11.5%
3 Consumer Discretionary 8.61%
4 Healthcare 6.52%
5 Financials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLRY icon
1876
Tilray
TLRY
$649M
$46.7K ﹤0.01%
3,512
+1,422
+68% +$20.9K
STTK icon
1877
Shattuck Labs
STTK
$793M
$45.3K ﹤0.01%
+37,400
New +$46.3K
ZVIA icon
1878
Zevia
ZVIA
$101M
$45.2K ﹤0.01%
+10,795
New +$22K
AACG
1879
ATA Creativity
AACG
$40.6M
$42.6K ﹤0.01%
50,388
-2,312
-4% -$2.18K
ABAT icon
1880
American Battery Technology Co
ABAT
$327M
$42.6K ﹤0.01%
+17,300
New +$19.4K
RVNC
1881
DELISTED
Revance Therapeutics, Inc.
RVNC
$40.7K ﹤0.01%
13,400
-48,900
-78% -$213K
PMCB icon
1882
PharmaCyte Biotech
PMCB
$5.64M
$40.3K ﹤0.01%
25,700
-200
-0.8% -$345
NGD
1883
DELISTED
New Gold Inc
NGD
$39.4K ﹤0.01%
+15,900
New +$43.9K
CCIRW
1884
DELISTED
Cohen Circle Acquisition Corp. I Warrant
CCIRW
$38.1K ﹤0.01%
+85,000
New +$31.7K
KWEB icon
1885
PUT
KraneShares CSI China Internet ETF
KWEB
$5.18B
$38K ﹤0.01%
1,300
-198,700
-99% -$6.38M
ANTX icon
1886
AN2 Therapeutics
ANTX
$212M
$37.1K ﹤0.01%
26,900
-39,200
-59% -$47.5K
REFR icon
1887
Research Frontiers
REFR
$16.3M
$34.9K ﹤0.01%
20,400
ILLR
1888
Triller Group Inc
ILLR
$16.4M
$31.8K ﹤0.01%
+1,337
New +$48.8K
BTG icon
1889
B2Gold
BTG
$7.56B
$29.5K ﹤0.01%
+12,100
New +$35.5K
BLIN icon
1890
Bridgeline Digital
BLIN
$12.1M
$28.9K ﹤0.01%
18,300
-200
-1% -$243
ANSCW
1891
DELISTED
Agriculture & Natural Solutions Acquisition Corp Warrant
ANSCW
$27K ﹤0.01%
100,000
+75,000
+300% +$20.4K
OMH icon
1892
Ohmyhome Ltd
OMH
$8.27M
$25.9K ﹤0.01%
6,480
-390
-6% -$1.58K
IFRX icon
1893
InflaRx
IFRX
$302M
$25.5K ﹤0.01%
10,344
-7,756
-43% -$14.9K
BDSX icon
1894
Biodesix
BDSX
$268M
$24.1K ﹤0.01%
+786
New +$23.1K
LEDS icon
1895
SemiLEDS
LEDS
$15.3M
$23.7K ﹤0.01%
18,400
+200
+1% +$254
LDI icon
1896
loanDepot
LDI
$301M
$21.7K ﹤0.01%
+10,661
New +$23.8K
CARV
1897
DELISTED
Carver Bancorp
CARV
$19.1K ﹤0.01%
10,400
-100
-1% -$176
NXTC icon
1898
NextCure
NXTC
$27M
$16.8K ﹤0.01%
1,817
-166
-8% -$2.44K
BDMDW
1899
Baird Medical Investment Holdings Warrant
BDMDW
$10.3K ﹤0.01%
+50,000
New +$1.98K
LPAAW
1900
Launch One Acquisition Corp Warrant
LPAAW
$1.73M
$10.1K ﹤0.01%
+75,000
New +$7.21K

Similar funds

Steve Schonfeld's Q4 2024 Portfolio in Review

As of Q4 2024, Steve Schonfeld held 2,528 positions worth $17.2B, up 15% from $15B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Steve Schonfeld deployed $1.86B of net new capital in Q4 2024, opening 540 new positions and adding to 670 existing holdings. Its largest new stake was Invesco MSCI USA ETF: 1,520,000 shares worth $89.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $144M trimmed.

  • Steve Schonfeld's largest Q4 2024 buy was Invesco MSCI USA ETF: 1,520,000 shares worth $89.5M.
  • Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $1.67B increase.
  • Steve Schonfeld's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $144M.
  • Steve Schonfeld fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2024, selling an estimated $40.7M.
  • Steve Schonfeld's ten largest holdings make up 36% of its $17.2B portfolio in Q4 2024.
  • Steve Schonfeld opened 540 new positions and closed 576 in Q4 2024.
  • Steve Schonfeld's portfolio value rose 15% quarter-over-quarter to $17.2B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.